ACHILLION PHARMACEUTICALS INC - FORM 10-Q - EX-32.2 - SECTION 906 CFO CERTIFICATION - November 8, 2011
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Achillion Pharmaceuticals, Inc. (the Company) for the quarter ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Mary Kay Fenton, Chief Financial Officer of the Company, hereby certifies, pursuant to Section 1350 of Chapter 63 of Title 18, United States Code, that:
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.